How to Get a Private Prescription for Mounjaro in the UK

What makes a private Mounjaro prescription different from an NHS one?

The medicine is identical. The difference is the route and the waiting time. On the NHS, tirzepatide is recommended by NICE (TA1026) for a specific and currently limited group (adults with a BMI of 35 or above plus at least one qualifying condition) and access is being phased in over several years, with many GP practices still not participating. The gap between NHS eligibility and private eligibility is significant. Private prescribing follows the licensed criteria in the Mounjaro SmPC: adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds may apply for some ethnic backgrounds under UK clinical guidance.

A private prescription isn't a loophole. It is the standard, legal route for any Prescription-Only Medicine when a person pays for their own treatment rather than receiving it through the NHS. What matters is that the prescriber is properly registered, the pharmacy is GPhC-regulated, and the supply chain is licensed. You can read more about what private Mounjaro treatment involves if you'd like a fuller picture before starting.

One thing worth knowing: if you are wondering whether Mounjaro jabs are available on the NHS in your area, the answer depends on where you live and whether your GP practice has begun offering them, since rollout remains patchy across the UK. Most do not stock it, and a specialist online pharmacy with its own dispensing operation is the practical answer for the vast majority of patients in the UK today.

How does the clinical assessment for a private Mounjaro prescription actually work?

The assessment matters because Mounjaro is not suitable for everyone. A prescriber will look at your BMI, your weight-related health history, any medicines you currently take, and whether there are contraindications, conditions or circumstances that would make Mounjaro unsuitable for you. Pregnancy, breastfeeding, or trying to conceive rule it out; a personal or close family history of medullary thyroid carcinoma or certain other conditions requires careful consideration. The prescriber also needs to be confident the person they are assessing is who they say they are, and that the weight recorded is accurate.

At nume, that means photo-ID verification and a brief live video check for weight. It also means your GP receives a notification in line with GPhC guidance, so your wider healthcare team is aware. If you are transferring from another provider or requesting a dose above the starting level, evidence of your current treatment is required before a prescriber will review the request. None of that is bureaucracy for its own sake, it is what responsible prescribing looks like. More on the eligibility criteria is available if you want the detail before you apply.

Treatment, if approved, begins at 2.5mg, a tolerability dose designed to let your system adjust before the prescriber considers moving you up. Titration decisions rest entirely with the prescriber and are not pre-set.

How do you know whether an online pharmacy offering Mounjaro is legitimate?

The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, including fake tirzepatide. In October 2025 investigators raided the first illicit UK manufacturing site producing counterfeit Mounjaro pens. The safest check is fast and free: the GPhC publishes a public register of every registered pharmacy premises in England, Scotland and Wales at pharmacyregulation.org/registers. You can verify nume's own GPhC premises registration (9012878) directly there.

Red flags to watch for: any seller offering Mounjaro without requiring a prescription or clinical assessment; prices far below the current market range; social media accounts selling pens; discount codes attached to Prescription-Only Medicines. The MHRA's Yellow Card scheme lets you report both suspected side effects and suspect sellers, a useful avenue if you encounter anything that doesn't look right.

Genuine supply chains in the UK run through Eli Lilly's authorised distribution network. At our pharmacy, Mounjaro is sourced exclusively through that licensed UK supply chain. Plain packaging and DPD tracking mean your pen arrives discretely and verifiably, check the tracking on your phone, and keep it in the fridge when it arrives.

What happens after the prescription is issued?

Once a prescriber approves your consultation, our GPhC-registered pharmacy dispenses your Mounjaro and books a DPD collection for same-day dispatch, provided you ordered before 12pm on a working day. The pen arrives the next working day at the address you provided. There is no subscription attached to this; every repeat order is submitted as a new request and reviewed clinically again before anything is sent.

Aftercare is included. Our prescribers are available seven days a week if questions come up after your pen arrives. Repeat prescriptions follow the same review process as your first, the prescriber checks in, considers your progress, and confirms suitability before the next supply is released. If at any point something concerns you (symptoms that worry you, questions about your treatment, anything) the clinical team is reachable directly. You can also browse our FAQs for common questions about starting treatment.

For a fuller look at Mounjaro and what the treatment involves from the start, the Mounjaro overview page covers the evidence, how the medicine works, and what to expect. When you're ready, start your free consultation and a prescriber will review your answers the same day.